GURJEET MAHAL: Open Payments
NPI 1194759704 · FREMONT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 34 payments from 11 companies in 2025. Trend: 2023 $615 · 2024 $815 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 4 | $220 |
| Novartis Pharmaceuticals Corporation | 10 | $193 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $160 |
| Novo Nordisk Inc | 2 | $124 |
| PFIZER INC. | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Amgen Inc. | 2 | $40 |
| HEARTFLOW, INC. | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Octapharma USA, Inc. | 1 | $19 |
Products named: Attruby, LEQVIO, LifeVest, Wegovy, VYNDAQEL, Kerendia, Repatha, FFRct.
Industry payments across CA — which companies pay providers there.
